Pennsylvania Patent of the Month – May 2024
Lifeware Labs, LLC has been granted a patent for a wearable device with technology that represents a significant leap forward in continuous physiological monitoring.
By integrating a pulse oximeter, EKG electrodes, and a mechanical spring mechanism into a single wearable patch, this invention opens up new possibilities for monitoring vital signs without the need for multiple devices or invasive procedures.
Traditionally, monitoring blood pressure required bulky and uncomfortable equipment, limiting mobility and convenience. Lifeware Labs recognized this challenge and developed a solution that combines the accuracy of EKG and pulse oximetry with the portability of wearable technology.
The key innovation lies in the mechanical spring mechanism incorporated into the base of the patch. This mechanism ensures intimate contact between the pulse oximeter and the user’s skin, optimizing the quality of data collected without compromising comfort. By applying a compressive force perpendicular to the skin’s surface, the pulse oximeter can accurately measure pulse transit time, a crucial metric for estimating blood pressure.
The patch is designed for continuous wear, enabling real-time monitoring of physiological data without user intervention. The integration of a microprocessor and wireless connectivity allows for seamless data transmission to external devices, such as smartphones or tablets, empowering users to track their health status effortlessly.
But the benefits of this invention extend beyond convenience. Lifeware Labs envisions a future where continuous monitoring becomes the norm, revolutionizing healthcare delivery and empowering individuals to take proactive measures towards their well-being.
The company is first focused on delivering ProPatch™ for combat medics and first responders, providing much needed tracking and metrics in the field, when every second matters. By applying the patch to the patient, data is immediately tracked and transferred to the paramedic’s phone. In the case of military applications, in can integrate with the U.S. Air Force Battlefield Assisted Trauma Distributed Observation Kit. In addition, the devices can take in data from multiple patches so that multiple patients can be monitored at once.
The potential applications of this technology are vast. Military personnel deployed in remote areas, civilians engaging in outdoor activities, or patients recovering at home can all benefit from continuous physiological monitoring. By providing actionable insights into heart health, the wearable device has the potential to save lives and improve quality of life worldwide.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.